Zobrazeno 1 - 10
of 19
pro vyhledávání: '"P. M. Grosheide"'
Autor:
L J Gerards, J A Mazel, G.C. de Gast, W.P.F. Fetter, R. del Canho, J. Zwijneberg, Wim C. J. Hop, R. A. Heijtink, P. M. Grosheide, Solko W. Schalm
Publikováno v:
Vaccine, 15(15), 1624-1630. Elsevier
From 1982 to 1989, 705 infants born to HBsAg-positive mothers entered the Dutch neonatal hepatitis B vaccination program and received passive-active hepatitis B immunization in three randomized controlled trials testing variations in time of starting
Publikováno v:
Prenatal Diagnosis. 14:553-558
From 1982 to 1989, pregnant women in two large city hospitals in The Netherlands had serum samples screened for hepatitis B surface antigen (HBsAg). Infants of mothers found to be HBsAg-positive received hepatitis B immune globulin immediately after
Publikováno v:
Vaccine. 12:1059-1063
The need for an additional dose of hepatitis B immune globulin (HBIg) was studied by comparing infants receiving 1 ml HBIg at birth followed by hepatitis B immunization, concomitant with DTP-polio vaccine, at 3, 4, 5 and 11 months (schedule E), with
Publikováno v:
Vaccine. 9:682-687
Women (175) who participated in an in vitro fertilization (IVF) programme were possibly exposed to hepatitis B virus. Later it became evident that 79 women had a hepatitis B infection, 49 were exposed but not infected and 47 were not exposed. Hepatit
Autor:
J W Wladimiroff, S W Schalm, J A Mazel, R A Heijtink, A S M Nuijten, P. M. Grosheide, G. C. M. L. Christiaens
Publikováno v:
BMJ. 311:1197-1199
Objective: To develop a low cost, high compliance screening programme for identification of carriers of hepatitis B surface antigen in the obstetric population of the Netherlands. Design: A seven year open, descriptive study of screening for hepatiti
Publikováno v:
BMJ. 311:1200-1202
Objectives: To launch a programme for the prevention of perinatal infection with hepatitis B in the Netherlands. Design: Routine antenatal screening and intervention programme. Setting: Community antenatal programme, the Netherlands. Subjects: Infant
Autor:
Solko W. Schalm, M. Voogd-Schotanus, R. del Canho, P. M. Grosheide, R. A. Heijtink, W. M. Huisman
Publikováno v:
Vaccine. 12(14)
The immunogenicity of a half (5 micrograms) and a full (10 micrograms) dosage of recombinant DNA yeast-derived hepatitis B vaccine (HB-Vax-DNA) in healthy neonates was assessed in order to compare two candidate dosages of vaccine. After randomization
Publikováno v:
Vaccine. 12(12)
The need for an additional dose of hepatitis B immune globulin (HBIg) was studied by comparing infants receiving 1 ml HBIg at birth followed by hepatitis B immunization, concomitant with DTP-polio vaccine, at 3, 4, 5 and 11 months (schedule E), with
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 137(50)
To describe the viral, clinical and biochemical course of infants, who, in spite of passive-active hepatitis B immunisation, became infected with hepatitis B.Prospective cohort study.The Netherlands.As part of the research programme of the Dutch stud
Autor:
P M, Grosheide, A L, den Ouden, G H, Verrips, M A, Conyn-van Spaendonck, J G, Loeber, S P, Verloove-Vanhorick
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 137(50)
To evaluate the effectiveness of the national programme for prevention of perinatal hepatitis B infections.The regional public health laboratories and provincial immunization administrations in the Netherlands.Retrospective evaluation.Starting Octobe